Serological and genetic factors in early recurrence of IgA nephropathy after renal transplantation

Clinical Transplantation

Volumn 21, Issue 6, 2007, Pages 728-737

  Coppo, Rosanna ^a   Amore, Alessandro ^a   Chiesa, Monica ^a   Lombardo, Federica ^a   Cirina, Paola ^a   Andrulli, Simeone ^b   Passerini, Patrizia ^c   Conti, Giovanni ^a   Peruzzi, Licia ^a   Giraudi, Roberta ^a   Messina, Maria ^a   Segoloni, Giuseppe ^a   Ponticelli, Claudio ^d  

^a Nephrology Dialysis and Transplantation Unit   (Italy)

^b Nephrology Dialysis and Transplantation Unit   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

Aberrantly glycosylated IgA; Genetic factors; IgA nephropathy; Kidney transplantation; Recurrence

Indexed keywords

ANGIOTENSIN II; ANGIOTENSINOGEN; CARRIER PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MESANGIUM CELL; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; RISK FACTOR;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; BIOLOGICAL MARKERS; BIOPSY; CYTOKINES; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 35848960375     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2007.00730.x     Document Type: Article

References (31)

1. Kessler M, Hiesse C, Hestin D, Mayeux D, Boubenider K, Charpentier B. Recurrence of immunoglobulin A nephropathy after renal transplantation in the cyclosporine era. Am J Kidney Dis 1996: 28: 99.
2. Bumgardner GL, Amend WC, Ascher NL, Vincenti FG. Single-center long-term results of renal transplantation for IgA nephropathy. Transplantation 1998: 65: 1053.
3. Odum J, Peh CA, Clarkson AR et al. Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 1994: 9: 309.
4. Floege J. Recurrent IgA nephropathy after renal transplantation. Semin Nephrol 2004: 24: 287.
5. Ponticelli C, Traversi L, Feliciani A, Cesana BM, Banfi G, Tarantino A. Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int 2001: 60: 1948.
6. Wang AY, Lai FM, Yu AW et al. Recurrent IgA nephropathy in renal transplant allografts. Am J Kidney Dis 2001: 38: 588.
7. Brensilver JM, Mallat S, Scholes J, Mc Cabe R. Recurrent IgA nephropathy in living-related donor transplantation: Recurrence or transmission of familial disease? Am J Kidney Dis 1988: 12: 147.
8. Choy BY, Chan TM, Lo SK, Lo WK, Lai KN. Renal transplantation in patients with primary immunoglobulin A nephropathy. Nephrol Dial Transplant 2003: 18: 2399.
9. Coppo R, Amore A, Cirina P et al. IgA serology in recurrent and non-recurrent IgA nephropathy after renal transplantation. Nephrol Dial Transplant 1995: 10: 2310.
10. Allen AC, Harper SJ, Feehally J. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 1995: 100: 470.
11. Tomana M, Matousovic K, Julian BA, Radl J, Konecny K, Mestecky J. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 1997: 52: 509.
12. Hiki Y, Tanaka A, Kokubo T et al. Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Am Soc Nephrol 1998: 9: 577.
13. Amore A, Cirina P, Conti G, Brusa P, Peruzzi L, Coppo R. Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. J Am Soc Nephrol 2001: 1812: 1862.
14. Jennette JC, Wieslander J, Tuttle R, Falk RJ. Serum IgA-fibronectin aggregates in patients with IgA nephropathy and Henoch-Schonlein purpura: Diagnostic value and pathogenic implications. The glomerular disease collaborative network. Am J Kidney Dis 1991: 18: 466.
15. Zheng F, Kundu GC, Zhang Z, Ward J, De Mayo F, Mukherjee AB. Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice. Nat Med 1999: 5: 1018.
16. Coppo R, Chiesa M, Cirina P, Peruzzi L, A more A. European IgACE Study Group: In human IgA nephropathy uteroglobin does not play the role inferred from transgenic mice. Am J Kidney Dis 2002: 40: 495.
17. Coppo R, Amore A, Gianoglio B et al. Serum IgA and macromolecular IgA reactive with mesangial matrix components. In: BenéMC, Faure GC, Kessel M eds. Contrib Nephrol IgA Nephropathy: The 24th Year. Basel: Karger, 1993: 162
18. Chintalacharuvu SR, Nagy NU, Sigmund N, Nedrud JG, Lamm ME, Emancipator SN. T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation. Clin Exp Immunol 2001: 126: 326.
19. Romagnani S. T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 2000: 85: 9.
20. Barratt J, Feehally J, Smith AC. Pathogenesis of IgA nephropathy. Semin Nephrol 2004: 24: 197.
21. Coppo R, Amore A, Gianoglio B et al. Angiotensin II local hyper reactivity in the progression of IgA nephropathy. Am J Kidney Dis 1993: 21: 593.
22. Del Prete D, Gambaro G, Lupo A et al. Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Kidney Int. 2003: 64: 149.
23. Damjanov I. Lectin cytochemistry and histochemistry. Lab Invest 1987: 57: 5.
24. Novak J, Tomana M, Kilian M et al. Heterogeneity of O-glycosylation in the hinge region of human IgA1. Mol Immunol 2000: 37: 1047.
25. Linossier MT, Palle S, Berthoux F. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: Normal versus thin. Am J Kidney Dis 2003: 41: 558.
26. Coppo R, Amore A. Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int 2004: 65: 44.
27. Coppo R, D'Amico G. Factors predicting progression of IgA nephropathies. J Nephrol 2005: 18: 503.
28. Tuglular S, Berthoux P, Berthoux F. Polymorphisms of the tumor necrosis factor α gene at position -308 and TNFα nicrosatellite in primary IgA nephropathy. Nephrol Dial Transplant 2003: 18: 724.
29. So T, Salek-Ardakani S, Nakano H, Ware CF, Croft M. TNF receptor-associated factor 5 limits the induction of Th2 immune responses. J Immunol 2004: 172: 92.
30. Bantis C, Heering PJ, Aker S, Klein-Vehne N, Grabensee B, Ivens K. Association of interleukin-10 gene G-1082A polymorphism with the progression of primary glomerulonephritis. Kidney Int 2004: 66: 288.
31. Ebihara I, Hirayama K, Yamamoto S, Muro K, Yamagata K, Koyama A. Th2 predominance at the single-cell level in patients with IgA nephropathy. Nephrol Dial Transplant 2001: 16: 1783.